New York Cardiovascular Symposium
December 9 − 11, 2016
New York Hilton Midtown
New York City

Course Director(s): Valentin Fuster, MD, PhD, MACC

Conflict of Interest (COI) Policy / Disclosures

ACCF committee members, faculty, staff and other individuals who are in a position to control the content of this activity are required to disclose all relevant financial relationships he/she and/or his/her spouse or domestic partner has, occurring within the past twelve months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. All relevant potential conflicts of interest that are identified are thoroughly vetted through a process that includes course directors and appropriate peer review by education committee chairs/members, for fair balance, scientific objectivity and validity, patient care and safety recommendations. Refer to the links below for committee member disclosures and course faculty disclosures. Please note ACCF staff involved with this course have nothing to disclose.

Pre-Conference: Managing Dyslipidemia and ASCVD Risk: Lessons Learned Along the Pathways Slides:

What have we learned since 2013 AHA/ACC updated guidelines
Dr. Virani

Putting it all together: The 2016 ECDP on non-statin therapies
Dr. Morris

Case Challenge Model
Dr. Birtcher 

2016 NEW YORK CARDIOVASCULAR SYMPOSIUM SLIDES:

You have two convenient options to access the information from the conference:

  1. PDFs of Slides: To view the PDF versions of the slides, click on the blue "Download PDF" links below.
  2. Video of Sessions: To view the video for each session, click the "Watch Presentation" link at the beginning of each session. To find an individual presentation or slide you want within a session, simply click on that session and search by clicking on the magnifying glass icon on the control bar (see sample icon below). You may enter all or part of the presentation title, or any key word that you remember from the slides within that presentation. When the Search Results appear, click the hyperlink time stamps and jump straight to that part of the presentation that mentions your search term.


AGENDA
7:15 a.m. Shalom Jacobovitz
Chief Executive Officer
American College of Cardiology

Richard A. Chazal, MD, FACC
President
American College of Cardiology

Timothy J. Malins, MD, FACC
President, New York State Chapter
American College of Cardiology

Friday, December 9

Coronary Artery Disease -- Challenges in 2016
Session I: New Frontiers
Dr. Bhatt, Presiding

Watch Presentation
7:30 a.m. New Frontiers in Cardiovascular Scientific and Funding Challenges
From Disease to Health, From Aging to Birth
Dr. Fuster
Download PDF
8:00 a.m. New Frontiers in Atherosclerotic Disease and Myocardial Infarction
From Local Inflammation to Systemic Progenital Stem Cells Reaction  

Dr. Nahrendorf
Download PDF
8:25 a.m. New Frontiers in the Evolving Field of Omics
From Generic to a Personalized Cardiovascular Disease Management

Dr. Roberts
Download PDF
8:50 a.m. Panel Discussion
Drs. Fuster, Nahrendorf and Roberts

Session II: Acute Coronary Syndromes (ACS)
Dr. Halperin, Presiding

Watch Presentation
9:40 a.m. STEMI 1 - Timing to Reperfusion/Reperfusion Injury
A Multi-Layer Challenge to Decrease Infarct Size

Dr. Ibanez
Download PDF
10:05 a.m. STEMI 2 – Complete vs. Lesion Only Primary PCI
Towards a Personalized Approach

Dr. Bhatt

Download PDF
10:30 a.m. STEMI vs. NSTEMI vs. STABLE CAD – Post PCI Optimal DAPT Duration    
Scoring the Complexity of Stenting and Disease

Dr. Yeh

Download PDF
10:55 a.m. STEMI vs. NSTEMI vs. STABLE CAD – Five Challenging Cases  
Five Challenging Antithrombotic Approaches

Dr. Halperin

Download PDF
11:25 a.m. Panel Discussion
Drs. Bhatt, Halperin, Ibanez and Yeh

Session III: Chronic Coronary and Systemic Arterial Disease
Dr. Gersh, Presiding

Watch Presentation
1:00 p.m. Complex Stable CAD -- Evolving Management Strategies
Anatomy (SYNTAX), Ischemia (FFR) and the Microcirculation (PET, CT, MRI)

Dr. Fuster
Download PDF
1:25 p.m. Revascularization in Severe Left Ventricular Dysfunction
Approach and is the Assessment of Viability is Still Viable?

Dr. Gersh

Download PDF
1:45 p.m. Acute Ischemic Stroke vs. Chronic Carotid Artery Stenosis
Evolving Acute Endovascular Approaches vs. Watching and Thinking

Dr. Yagaval

Download PDF
2:05 p.m. Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD
The Peripheral Academic Research Consortium (PARC)

Dr. Jones

Download PDF
2:25 p.m. Panel Discussion
Drs. Fuster, Gersh, Jones and Yagaval

Session IV: Trends and Challenges of Prevention
Dr. Chazal, Presiding

Watch Presentation
3:15 p.m. Chest Pain Evaluation
No Test, Stress Test or CT Angio?

Dr. Douglas
Download PDF
3:35 p.m. Aspirin Therapy in Primary Cardiovascular Disease (CVD) Prevention
Only for Those at High CVD Risk, the Dose under Trials

Dr. Patrono

Download PDF
3:55 p.m. Four Evolving “Thinkings” on Lipid Evaluation and Management  
Cholesterol Genetics, ApoB, HDL-Infflux Capacity and PCSK 9 Inhibitors  

Dr. Rader

Download PDF
4:15 p.m. Three Evolving “Thinkings” on Patients with High Blood Pressure (pHBP)
Identify All pHBP, Reduce Salt in all Foods and Personalize BP Rx Targets

Dr. Messerli

Download PDF
4:35 p.m. The Four “Links” of Obesity -- Diabetes, Fatty Liver, Cardiomyopathy and AF    
The Potential Benefit and Rapid Evolution of Bariatric Surgery
 
Dr. Farkouh
Download PDF
4:55 p.m. Panel Discussion
Drs. Douglas, Farkouh, Messerli, Patrono and Rader

5:30 p.m. Adjournment  

Saturday, December 10

Cardio-pulmonary and Electrical Failure 2015
Session V: Systolic Heart Failure and Basis for Management
Dr. O'Connor, Presiding

Watch Presentation
7:00 a.m. Imaging Diagnostic/Prognostic Approaches to Six Cardiomyopathies:
Myocarditis, Dilated, Amyloid, Sarcoid, Hypertrophic, Non-compaction

Dr. Garcia
Download PDF
7:25 a.m. Clinical/Therapeutic  Approaches to Three Specific Cardiomyopathies:
Acute/Subacute Myocarditis, AL/TTR Amyloid, Non-Compaction  

Dr. Dec

Download PDF
7:50 a.m. Systolic Dysfunction – Early Diagnosis and Therapeutic Advances
Prognostic Circulating Neprilysin and Therapeutic Neprilysin/Enalapril  

Dr. Bayes-Genis

Download PDF
8:15 a.m. Diastolic Dysfunction – Early Diagnosis and Therapeutic Failures
Should Management be Focused on the Comorbidities?

Dr. O’Connor
Download PDF
8:40 a.m. Support Devices for Acute CHF and Destination LVADs to Exclude Transplant
Expectations, Indications, Benefits and Risks

Dr. Mancini

Download PDF
9:05 a.m. State-of-the-Art Management of Pulmonary Arterial Hypertension:
Based on Understanding of the Various Etiopathogenesis

Dr. McLaughlin

Download PDF
9:30 a.m. Panel Discussion
Drs. Bayes-Genis, Dec, Garcia, Mancini, McLaughlin and O’Connor

Session VI: Rhythm Disorders, Contemporary and Future Topics of Focus
Dr. Reddy, Presiding

Watch Presentation
10:20 a.m. Innovations in Device Therapy and Follow-up Results
Subcutaneous ICDs, CRTs New Indications, Leadless Pacemakers  
 
Dr. Wilber
Download PDF
10:40 a.m. Ventricular Tachycardia: Catheter Ablation
Who? How? When? Results?

Dr. Reddy
Download PDF
11:00 a.m. Atrial Fibrillation:  Catheter Ablation
Who? How? When? Results?

Dr. Marchlinski

Download PDF
11:20 a.m. Atrial Fibrillation 2016 – The Fourteen Non-Ablation Clinical Challenges  
Quality of Life and Preventing Stroke

Dr. Fuster

Download PDF
11:40 a.m. Left Atrial Appendage Closure as an Alternative to Anticoagulants
Who? How? When? Results?

Dr. Holmes
Download PDF
12:00 p.m. Panel Discussion
Drs. Fuster, Holmes, Marchlinski, Reddy and Wilber

Valvular Heart Disease and Aorta — Challenges in 2016
Session VII: Management of Aortic Valve Disease, IHSS and Aorta
Dr. Leon, Presiding

Watch Presentation
1:30 p.m. Asymptomatic Severe Aortic Valvular Stenosis
Diagnostic Approaches and Therapeutic Strategies (LF/LG/NEF/LEF)

Drs. Leon and Vahl
Download PDF
1:55 p.m. Symptomatic Severe Aortic Valvular Stenosis (LF/LG/NEF/LEF)
TAVR in Patients at High, Moderate or Low Risk

Drs. Bavaria and Sharma

Download PDF Bavaria
Download PDF Sharma
2:20 p.m. Symptomatic & Asymptomatic Aortic Valvular Incompetence
From Medical Therapy to Surgical AVR to Transcatheter AVR (?)

Drs. Bonow and O’Gara
Download PDF
2:45 p.m. Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
Prevalence, Genetics, Natural History and Evolving Management

Dr. Maron
Download PDF
3:10 p.m. The Dilated Thoracic and Abdominal Aorta and Complicating Dissection
Evolving Understanding of the Basic Biology and Management

Dr. Fuster
Download PDF

3:35 p.m. Panel Discussion
Drs. Bavaria, Bonow, Fuster, Leon, Maron, O'Gara, Sharma and Vahl

Session VIII: Management of Mitral Regurgitation
Dr. Bavaria, Presiding

Watch Presentation
4:20 p.m. Symptomatic and Asymptomatic Secondary Mitral Regurgitation (EF, PH, AF)
From Medical Therapy to Surgical MVR to Transcatheter MVR (?)

Drs. Bavaria and Bonow
Download PDF
4:45 p.m. Symptomatic and Asymptomatic Primary Mitral Regurgitation  (EF, PH, AF)
From Medical Therapy to Surgical MVR to Transcatheter MVR

Drs O’Gara and Rodes-Cabau
Download PDF
5:10 p.m. Transcatheter Therapies for Mitral and Tricuspid Regurgitation
Evolving Approaches Under Investigation

Dr. Rodes-Cabau
Download PDF
5:30 p.m. Panel Discussion
Drs. Bavaria, Bonow, O'Gara and Rodes-Cabau

6:00 p.m. Adjournment  

Sunday, December 11

YEAR IN REVIEW: 10 HIGHLIGHTS OF PROGRESS IN 2016
Session IX: Novelties on Genetics, Cell Regeneration and Molecular Signaling
Dr. Fuster, Presiding

Watch Presentation
7:30 a.m. MicroRNAs and Genome Editing– Two Evolving Protagonists in Medicine
A New Understanding of Cardiovascular Physiology, Pathology and Future Therapies

Dr. Dorn
Download PDF
7:55 a.m. Induced Pluripotent Stem Cells and Direct Cardiac Reprogramming – Solving Barriers for a Powerful Future
The 2016 New Experimental and Clinical Information

Dr. Ieda
Download PDF
8:15 a.m. Gene Therapy Studies on the “Go” – Solving New Barriers
The 2016 New Cardiovascular Information  

Dr. Hajjar
Download PDF

Session X: Novelties on Diagnostic & Therapeutic Strategies

Watch Presentation
8:35 a.m. Diagnostic and Therapeutic Trends in Congenital Heart Disease
Watch the Next Decade

Dr. Newburger
Download PDF
8:55 a.m. An Evolving Reality of Medicine, Part Genetic, Part Acquired
Two Tangible Examples – The Long QT and The Brugada Syndrome

Dr. Brugada
Download PDF
9:15 a.m. The Rapid Progress of Cardiovascular Imaging
Redefining its Role in Biomedical Research and Clinical Practice

Dr. Di Carli
Download PDF
9:35 a.m. Handheld Echocardiography – It Depends What Hands are Holding it
Educational? Diagnostic? Overshadowing the Physical Examination?

Dr. Goldman
Download PDF
9:55 a.m. Hybrid Coronary Revascularization
An Evolving Paradigm in Coronary Care

Dr. Puskas
Download PDF

Session XI: Perspectives of the Future Based on the Past

10:35 a.m. HENRY RUSSEK LECTURE 2016
“The Heart Healers”
Rebels and Risk Takers Behind the Medical Breakthroughs of Our Lives

Dr. Forrester
Download PDF
11:10 a.m. PAUL DUDLEY WHITE LECTURE 2016
Experiences from the Platform of “60 Years of Observations”
A Few Reflections for the Medical and Cardiovascular Communities

Dr. DeSanctis
Download PDF
11:30 a.m. Course Adjournment